2019 meeting of the global virus network
The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 52 GVN Centers of Excellence and 9 Affiliate laboratories in 32 countries. The 11th International GVN meetin...
Gespeichert in:
Veröffentlicht in: | Antiviral research 2019-12, Vol.172, p.104645-104645, Article 104645 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 52 GVN Centers of Excellence and 9 Affiliate laboratories in 32 countries. The 11th International GVN meeting was held from June 9–11, 2019 in Barcelona, Spain and was jointly organized with the Spanish Society of Virology. A common theme throughout the meeting was globalization and climate change. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including severe virus epidemics, anticipation and preparedness for changing disease dynamics, host-pathogen interactions, zoonotic virus infections, ethical preparedness for epidemics and pandemics, one health and antivirals.
•The GVN is an international research network comprised of 52 Centers of Excellence and 9 Affiliates in 32 countries.•The 11th International GVN meeting was held from June 9–11, 2019 in Barcelona, Spain.•The meeting was jointly organized between GVN and the Spanish Society of Virology.•An important theme throughout the meeting was globalization and climate change.•The meeting provided an opportunity for discussion and networking, with a high participation of young Spanish virologists. |
---|---|
ISSN: | 0166-3542 1872-9096 1872-9096 |
DOI: | 10.1016/j.antiviral.2019.104645 |